Time-independent maternal and infant factors and time-dependent infant morbidities including HIV infection, contribute to infant growth faltering during the first 2 years of life

J Trop Pediatr. 2009 Apr;55(2):83-90. doi: 10.1093/tropej/fmn068. Epub 2008 Aug 22.

Abstract

Studies investigating the predictors of growth in infants born to HIV-infected women in developing countries are limited. Using data from 886 Tanzanian HIV-infected women and their infants, we examined the impact of maternal socioeconomic and immunological status, infant characteristics at birth, and HIV, diarrhea and respiratory infections on infants' monthly length-for-age (LAZ) and length-for-weight (WLZ) z-scores during the first 2 years of life. We used restricted cubic splines to estimate average adjusted growth curves by categories of each predictor. LAZ decreased significantly during the first 2 years. WLZ increased from birth to 4 months but decreased significantly thereafter. Greater maternal schooling significantly reduced deterioration in LAZ and WLZ scores from birth to 24 months, while maternal CD4 cell counts >or=200 mm(-3) at baseline were associated with reduced deterioration in LAZ scores. Infants born pre-term or with low-birth weight were significantly more stunted and wasted than their reference groups at all time points though their rate of growth faltering was slower. Infant-HIV status was strongly associated with significantly greater deterioration in LAZ and WLZ scores, beginning at about 4 months of age. Episodes of diarrhea or respiratory infections were related to significantly lower WLZ but not LAZ scores, independent of infant-HIV status. In conclusion, maternal schooling, immunological status and infant infections are important predictors of early growth in children born to HIV-positive women.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Child Development*
  • Child, Preschool
  • Cohort Studies
  • Diarrhea / complications
  • Diarrhea / epidemiology*
  • Female
  • Follow-Up Studies
  • Growth Disorders / epidemiology*
  • Growth Disorders / etiology
  • HIV Infections / complications
  • HIV Infections / epidemiology*
  • HIV Infections / transmission
  • HIV-1
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control
  • Male
  • Mothers
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / epidemiology*
  • Risk Factors
  • Socioeconomic Factors
  • Tanzania / epidemiology
  • Time Factors
  • Vitamin A / administration & dosage

Substances

  • Vitamin A